Du är här

2016-02-09

Novo Nordisk A/S : Trading in Novo Nordisk shares by board members, executives and associated persons on 8 February 2016

Bagsværd, Denmark, 9 February 2016
In accordance with Section 28a of the Danish Securities Trading Act, the
company's board members and executives have given Novo Nordisk power of
attorney on their behalf to publish trading in Novo Nordisk shares by the
company's board members, executives and their associated persons as reported
by those persons to Novo Nordisk.

Further information-----------------------------------------------------------------
| Media: |
| Anne Margrethe Hauge +45 4442 3450 amhg@novonordisk.com |
| Ken Inchausti (US) +1 609 514 8316 kiau@novonordisk.com |
| |
| Investors: |
| Peter Hugreffe Ankersen +45 3075 9085 phak@novonordisk.com |
| Daniel Bohsen +45 3079 6376 dabo@novonordisk.com |
| |
|Melanie Raouzeos +45 3075 3479 mrz@novonordisk.com |
|Kasper Veje +45 3079 8519 |
| kpvj@novonordisk.com |
-----------------------------------------------------------------
Company announcement No 11 / 2016

Company announcement No 11 / 2016
http://hugin.info/2013/R/1984718/727683.pdf

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Globenewswire

HUG#1984718

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.